Replies to post #92255 on Regen BioPharma Inc (RGBP)

[Skiluc]

I don't believe there is a buyout.

There is no Real evidence suggesting one side is more correct then another. What we Believe is personal opinion.

A company doesn't take out a convertible promissory note (from a dissolved private equity firm) if a buyout was coming. Why would a company go that route if a "Big Pharma" would just purchase them for "billions" of dollars?

Sure it does. Especially in the Medical field. In fact what is typical is certain milestones being required to be met. Like securing the IP. Duh. Dr. Koos, if in buyout discussions, would certainly be expected of securing the IP. Some purchasing companies cant even have the conversation until that point. He did what he needed to get the IP secured. And ill even go further in that Dr. Koos didnt have any specific Data to share until just now. Kind of necessary to continue any buyout discussions, at least i would think.

I have never seen it. Historical data has never shown it.

Look harder. Yes it does. All over. Loans right up to the DAY of acquisition.

You think a buyout is the only option to move forward?

I dont think anyone is actually saying that. More that its strong likelyhood. And absolutely not the only option. With as much IP as this company has in its possession. All the options are on the table with Regen. All of them.

Why haven't they been bought out?

Not all companies are for sale. Duh.

There are many small biotech companies in this field that have never been bought out.

Of course. And the flip side is true… there are small biotech companies in this field that are obviously gearing towards buyout, that were bought out.

Here what still hasnt been mentioned. The undeniables. As in NR2F6 and Regen owned IP in and around it. Including several specific compounds that control NR2F6. Property of Regen. Undeniable.

[Ramblo]

Have you considered that a company like Mimivax doesn't want to be bought out? If you are a scientist and have a team that has put in the work to get to a certain point, why would you want to stop? You want to finish the puzzle, solve the problem.

At least one reason why small biopharma companies don't get bought out is because they're doing just fine on their own.

In contrast, one main reason for buyouts is because the companies have a good idea or proven technology that isn't getting anywhere because the company isn't doing well financially, is poorly managed, or has issues that prevent it from successfully operating on their own. In these cases, large companies may take on the risk and debt to access the technology.